The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this statement.
timely completion of clinical studies, uncertainties related to the regulatory approval process, establishment of corporate alliances and other risks detailed from time to time in the company quarterly filings.
January 24th, 2005). FDA, Health Canada and the Chinese SFDA. MedMira's tests provide reliable, rapid diagnosis in just 3 minutes for the detection of human antibodies in human serum, plasma or whole blood for diseases such as HIV. The United States FDA and the SFDA in the People's Republic of China have approved MedMira's Reveal(TM) G2 and MiraWell(TM) Rapid HIV Tests, respectively.
Gene Defect Linked To Familial Nerve DisorderFDA Warns Against Home Tests From Canada
Biologists Find Stem Cell RegulatorAbbott Laboratories (ABT) And OraSure Technologies, Inc. (OSUR) Enter Agreement For OraQuick(R) ADVANCE(TM) Rapid HIV 1/2 Test
HALIFAX, Feb. 15 /PRNewswire FirstCall/ MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ:MMIRF) the global market leader in rapid flow through diagnostic technology, today announced that internationally renowned Stanford Medical University, Duke Medical University and Johns Hopkin's Medical Research University are currently using MedMira's FDA approved Reveal(TM) G2 Rapid HIV 1 Antibody Test's (Reveal(TM) G2) in their central labs. These leading medical research universities have chosen Reveal(TM) G2 over other FDA approved rapid HIV tests after routine evaluations. A recently released report by Stanford and Duke Universities shows the cost benefits of increased national HIV testing in the United States. hospitals for Jordan Hats For Girls
MedMira markets its rapid tests worldwide in such countries as the United States, Canada, South Africa and China. Its corporate offices and manufacturing facilities are located in Halifax, Nova Scotia, Canada with a representative office in Beijing, China.
the second year running, based on results of an independent United States CDC study (January 18th, 2005). hospitals due to its ease of use and quick time to obtain test results (only 3 minutes), compared to the other FDA approved tests which require 10 to 40 minutes to obtain results.
This news release contains forward looking statements, which involve risk and uncertainties and reflect the company's current expectation regarding future events. Actual events could materially differ from those projected herein and depend on a number of factors including, but not limited to, changing market conditions, successful and Boston Braves Hats
With a China CDC study placing MedMira's rapid test as number one for quality and consistency of results and the South African Medical Research Council's recent rating of MedMira's MiraWell(TM) HIV Test as Atlanta Braves Cap the primary test of choice, MedMira is gaining a strong international reputation in the global healthcare market. MedMira's most recent advancement was the launch of its Over the Counter (OTC) MiraCare(TM) Rapid HIV Test in Hong Kong and Macao (released Adidas Hat With Gold Plate
1 Rapid HIV Test Is The Choice Of Internationally Renowned Medical Institutes
MedMira's Reveal(TM) G2 and MiraWell(TM) rapid HIV tests are currently used in clinical laboratories and hospitals where professional counseling and patient treatment are immediately available.
Hermes Etoupe Belt
Jordan Caps Online
New Era 39thirty Vs 59fifty
Michael Kors Belt Red
New York New Era Cap
Michael Kors Belts
Chicago Bulls Cap New Era
Chicago Bears Hat
Nike Cap Red
Adidas Cap Green
Hermes Belt 2017
Brooklyn Dodgers Hat 47
Cleveland Indians Hat New Era
Hugo Boss Belt For Men
New Era Snapbacks 2015